UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D. C. 20549
____________
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act Of 1934
June
22, 2005
Date
of
Report (Date of earliest event reported)
___________________________________________________________
ACURA
PHARMACEUTICALS, INC.
(Exact
Name of Registrant as Specified in Charter)
___________________________________________________________
|
State
of New
York
|
|
1-10113
|
|
11-0853640
|
|
(State
of Other Jurisdiction of
Incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer Identification Number)
|
| |
|
|
|
|
616
N. North Court, Suite 120
Palatine,
Illinois 60067
(Address
of principal executive offices) (Zip Code)
(847)
705-7709
(Registrant’s
telephone number, including are code)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
o› Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o› Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17CFR
240.14a-12)
o› Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17CFR240.14d-2(b))
o› Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR
240.13e- 4(c))
Item
8.01 Other
Events
On
June
22, 2005, Acura Pharmaceuticals, Inc. (the "Company") issued a press release
announcing completion of bridge financing in the principal amount of $1 million
pursuant to the terms of that certain Loan Agreement by and among the Company
and Essex
Woodlands Health Venture V, L.P., Care Capital Investments II, L.P., Care
Capital Offshore Investments II, L.P., Galen Partners III, L.P., Galen Partners
International III, L.P., and Galen Employee Fund III, L.P.,
dated
June 22, 2005. A copy of the Company's press release is attached as Exhibit
99.1
hereto.
Item
9.01 Financial
Statements and Exhibits.
|
Exhibit
Number
|
Description |
| 99.1 |
Press
Release dated June 22, 2005 Announcing Completion of $1 Million
Bridge
Financing.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
| |
|
|
| |
ACURA
PHARMACEUTICALS, INC. |
|
|
|
| |
By: |
/s/ Peter
A. Clemens |
| |
Peter
A. Clemens |
| |
Vice
President & Chief Financial Officer |
| Date: June
22, 2005 |
|
EXHIBIT
INDEX
|
Exhibit
Number
|
Description |
| |
|
|
99.1
|
Press
Release dated June 22, 2005 Announcing Completion of $1 Million
Bridge
Financing.
|
| |
|